NewAmsterdam Pharma Company NV
Earnings Surprise
Analysts estimated NAMS earnings of $-0.39 per share this quarter (Q4). NAMS's actual earnings were $-0.62 per share.
NAMS EPS surprise of -57.84%Analysts estimated NAMS earnings of $-0.40 per share this quarter (Q3). NAMS's actual earnings were $-0.61 per share.
NAMS EPS surprise of -50.95%Analysts estimated NAMS earnings of $-0.50 per share this quarter (Q2). NAMS's actual earnings were $-0.15 per share.
NAMS EPS surprise of 70.09%Analysts estimated NAMS earnings of $-0.50 per share this quarter (Q1). NAMS's actual earnings were $-0.34 per share.
NAMS EPS surprise of 31.66%Analysts estimated NAMS earnings of $-0.50 per share this quarter (Q4). NAMS's actual earnings were $-0.93 per share.
NAMS EPS surprise of -87.61%Analysts estimated NAMS earnings of $-0.51 per share this quarter (Q3). NAMS's actual earnings were $-0.18 per share.
NAMS EPS surprise of 64.66%Analysts estimated NAMS earnings of $-0.59 per share this quarter (Q2). NAMS's actual earnings were $-0.41 per share.
NAMS EPS surprise of 30.32%Analysts estimated NAMS earnings of $-0.54 per share this quarter (Q1). NAMS's actual earnings were $-1.06 per share.
NAMS EPS surprise of -97.14%Analysts estimated NAMS earnings of $-0.61 per share this quarter (Q4). NAMS's actual earnings were $-0.58 per share.
NAMS EPS surprise of -4.67%Analysts estimated NAMS earnings of $-0.47 per share this quarter (Q3). NAMS's actual earnings were $-0.51 per share.
NAMS EPS surprise of 9.54%